Obesity
RecruitingZenagamtide for Weight Loss in Adults with Obesity
Zenagamtide for Weight Loss in Adults with Obesity
- Disease:Obesity
- Substances:–
Belgium- Participants:18–64 years · 65+ years
- Sponsor:Novo Nordisk A/S
Rare diseases
Investigational molecules
Locations
Back to Belgium516 clinical trials in Edegem, Belgium across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Zenagamtide for Weight Loss in Adults with Obesity
BelgiumA study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1
Belgium
BelgiumA study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity
BelgiumA study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.
BelgiumA Phase 3 Study of Fenfluramine Hydrochloride for Safety and Efficacy in Patients with Rett Syndrome
BelgiumPhase 2 Study of Rinatabart Sesutecan with Pegfilgrastim in Adults with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
BelgiumA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
BelgiumA study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis
BelgiumA study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.
BelgiumStudy of blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia
BelgiumComparing AZD5335 with mirvetuximab soravtansine or a drug combination in patients with platinum-resistant ovarian cancer
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on viral infections and vaccine development, including studies for influenza, RSV, and COVID-19. Multiple trials are evaluating immune responses and vaccine efficacy in different age groups.
Special attention is given to vulnerable populations, including elderly adults and pregnant women.
Innovative studies addressing Primary Biliary Cholangitis and Hepatitis D treatments. Research includes evaluation of novel therapeutics and their impact on disease progression.
Trials focus on improving patient outcomes and developing targeted treatments.
Advanced research in breast cancer and lung cancer treatments, exploring new therapeutic combinations and targeted approaches for better patient outcomes.
Focus on personalized medicine approaches and innovative treatment combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.